A Phase II Study of Single Agent Depsipeptide (FK228) in Metastatic or Unresectable Soft Tissue Sarcomas
Latest Information Update: 16 Jun 2017
At a glance
- Drugs Romidepsin (Primary)
- Indications Soft tissue sarcoma
- Focus Adverse reactions; Therapeutic Use
- 04 Apr 2017 Status changed from active, no longer recruiting to completed.
- 04 Apr 2017 Status changed from active, no longer recruiting to completed.
- 18 Jul 2012 Planned end date changed from 1 Jan 2006 to 1 Jan 2100 as reported by ClinicalTrials.gov. (NCT01645683)